$4.68 Billion Forecast for Mineral And Bone Disorder Treatment Market by 2029, Backed by Demand and Innovation
Discover trends, market shifts, and competitive outlooks for the mineral and bone disorder treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Is the Current and Projected Market Size of the Mineral And Bone Disorder Treatment Market Through 2034?
In recent times, the market for mineral and bone disorder treatments has seen substantial growth. The market, valued at $3.3 billion in 2024, is projected to reach $3.55 billion in 2025, implying a compound annual growth rate (CAGR) of 7.7%. Various factors like an increase in chronic kidney conditions, an aging population, heightened awareness of mineral and bone disorders, more available treatment options for these conditions, and an increase in disposable income are contributing to the growth observed in the historical period.
Expectations are high for significant expansion in the mineral and bone disorder treatment market in the coming years. The market is estimated to hit $4.68 billion by 2029, with a compound annual growth rate (CAGR) of 7.1%. The projected growth within the forecast period is largely down to an increasing interest in quality of life treatments, demand for tailored medication, government healthcare expenditures, and growing consciousness of the need for early detection. The forecast period will also see major trends like medical research advancements, enhancements in pharmaceuticals, digital health growth, biologic therapies, telehealth and remote patient monitoring.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12956&type=smp
What Are the Core Growth Drivers Propelling the Mineral And Bone Disorder Treatment Market Forward?
The growth of the mineral and bone disorder treatment market is anticipated to be spurred on by the expanding elderly population. Defined as individuals aged 65 or more, the elderly population often experiences muscle and bone mass loss, resulting in weakness and diminishing strength. This makes mineral and bone treatment crucial in hindering age-related changes in muscles, bones, and joints, and in maintaining bone strength and slowing down bone loss. For instance, data from the House of Commons Library of UK’s Parliament in July 2024 stated that in 2022, 12.7 million people or 19% of the UK population were aged 65 or older. This statistic is predicted to surge to 22.1 million by 2072, accounting for 27% of the populace. Therefore, the expanding elderly population is fueling the growth of the mineral and bone disorder treatment market. Rising cases of chronic kidney diseases are also projected to push forward the expansion of the mineral and bone disorder treatment market. Chronic kidney disease (CKD) is a gradually advancing medical condition where the kidneys progressively lose their capacity to function effectively. The focus of mineral and bone disorder treatment in chronic kidney diseases is to maintain a proper mineral balance, safeguard bone health, and minimize the risk of complications connected to these imbalances. For instance, as per the National Library of Medicine, a US-based medical library in March 2022, over 800 million people all around the globe, or 10% of the total population, suffer from chronic kidney disease, a degenerative disorder. Consequently, the increasing cases of chronic kidney diseases are contributing to the growth of the mineral and bone disorder treatment market.
What Segment Types Define the Mineral And Bone Disorder Treatment Market Structure?
The mineral and bone disorder treatment market covered in this report is segmented –
1) By Treatment: Diet, Nutrition, Medication, Supplements, Dialysis
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Diet: Calcium-Rich Foods, Vitamin D-Enriched Foods, Phosphorus-Rich Foods
2) By Nutrition: Nutritional Counseling, Fortified Food Products, Meal Replacement Programs
3) By Medication: Bisphosphonates, Hormonal Therapies, RANK Ligand Inhibitors
4) By Supplements: Calcium Supplements, Vitamin D Supplements, Multivitamin Supplements
5) By Dialysis: Hemodialysis, Peritoneal Dialysis, Continuous Renal Replacement Therapy (CRRT)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12956&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Mineral And Bone Disorder Treatment Market?
North America was the largest region in the mineral and bone disorder treatment market in 2024. The regions covered in mineral and bone disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which Emerging Trends that Are Influencing theMineral And Bone Disorder Treatment Industry Evolution?
In an effort to consolidate their market position, major businesses in the mineral and bone disorder treatment sector are concentrating on the development and approval of innovative products. The approval rate for mineral and bone drugs is escalating in response to the growing aged population and the rising incidence of chronic kidney diseases such as TYMLOS (abaloparatide), a product which includes the potent drug abaloparatide, a lab-created version of the human parathyroid hormone. For instance, in December 2022, Radius Health Inc., a biopharmaceutical organization based in the United States, attained approval for TYMLOS (abaloparatide). This parathyroid hormone-related peptide (PTHrP (1-34)) analog helps augment bone density in men suffering from osteoporosis who have a high risk of fractures. The agent stimulates the parathyroid hormone 1 receptor (PTH1R) found in osteoblasts and osteocytes, resulting in an enhancement of bone creation and density.
View the full report here:
What Is the Definition of the Mineral And Bone Disorder Treatment Market?
Mineral and bone disorder treatment refers to a treatment procedure recommended when there is an imbalance in the levels of calcium and phosphorus in the blood. The treatment regulates the levels of certain minerals and hormones in the blood to prevent bone and blood vessel damage.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12956
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
